<DOC>
	<DOC>NCT01761695</DOC>
	<brief_summary>The investigators would like to propose a prospective longitudinal observational cohort study for patients who will be diagnosed and/or treated for chronic myeloid leukemia at Asan Medical Center, Seoul, Korea, to use the acquired data for fundamentals of other retrospective analysis.</brief_summary>
	<brief_title>Chronic Myelod Leukemia Registry at Asan Medical Center</brief_title>
	<detailed_description>1. Acquisition of informed concent form 2. Data acquisition from medical record including - demographic / disease-associated factors - details of treatment, and its results - complications during treatment - genetic data - survival outcome (upto 30 years) 3. Accumulation of data for 30 years 4. Use of data for other retrospective analysis (including Asan Medical center Cell Banking basic data)</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia, Myeloid</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Leukemia, Myelogenous, Chronic, BCR-ABL Positive</mesh_term>
	<mesh_term>Leukemia, Myeloid, Chronic-Phase</mesh_term>
	<mesh_term>Leukemia, Myeloid, Accelerated Phase</mesh_term>
	<criteria>All patients who are diagnosed and/or treated as chronic myeloid leukemia at Asan Medical Center 15 years of age and over All patients who give written consent according to guidelines at Asan Medical Center committee on human research Patients who refuse to give consent to registering</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>